Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	581	627	151	95	71	70
Market Cap Growth	316.72%	316.72%	57.92%	34.76%	0.89%	1046.92%
Enterprise Value	457	544	124	49	30	35
Last Close Price	13.28	13.80	4.89	3.86	2.93	3.43
PS Ratio	21.00	28.18	5.98	37.37	288.92	226.06
PB Ratio	4.16	4.31	6.66	8.09	2.26	2.49
P/TBV Ratio	4.17	4.31	6.66	8.09	2.26	2.49
P/FCF Ratio	-	-	-	61.25	-	-
P/OCF Ratio	-	-	-	19.39	-	-
EV/Sales Ratio	20.50	24.43	4.94	19.10	122.30	113.31
EV/FCF Ratio	-	-	-	31.31	-	-
Debt / Equity Ratio	0.01	0.01	0.10	0.22	0.09	0.01
Debt / FCF Ratio	-	-	-	1.64	-	-
Asset Turnover	0.19	0.19	0.46	0.06	0.01	0.01
Quick Ratio	7.70	7.70	1.59	1.78	8.54	11.01
Current Ratio	7.77	7.77	1.63	1.82	8.82	11.33
Return on Equity (ROE)	-48.16%	-48.16%	-129.63%	-134.49%	-67.23%	-77.95%
Return on Assets (ROA)	-23.21%	-23.21%	-27.66%	-40.60%	-34.46%	-37.42%
Return on Capital (ROIC)	-30.98%	-30.98%	-76.81%	-76.41%	-41.71%	-48.40%
Earnings Yield	-6.67%	-6.45%	-14.80%	-30.43%	-28.30%	-19.47%
FCF Yield	-6.85%	-6.62%	-18.36%	1.63%	-25.45%	-15.12%
Buyback Yield / Dilution	-31.52%	-31.52%	-9.06%	-6.34%	-48.28%	-319.55%

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q